Back to the Future of Public Health

Am J Public Health. 2021 Apr;111(4):596-597. doi: 10.2105/AJPH.2021.306176.

Author

Julie Louise Gerberding¹

Affiliation

¹ The author is executive vice president and chief patient officer at Merck & Co. Inc. and the former director of the Centers for Disease Control and Prevention (2002-2009).

No abstract available

MeSH terms

COVID-19*
Centers for Disease Control and Prevention, U.S. / economics*
Financing, Government*
Health Personnel
Humans
Public Health / economics*
Resource Allocation / economics*
United States